Andrew Hykes is COO at Inari Medical, Inc. (NARI). They have made 33 open-market trades across 1 company since 2020, most recently 2026-10-05.
CIK 0001806431
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $48K since 2020, against 32 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NARI | SELL · 10b5-1 | 2024-12-20 | 2024-12-20 | $55.29 | $166K | -10.2% | +43.4% | N/A |
| NARI | SELL · 10b5-1 | 2024-11-20 | 2024-11-22 | $50.83 | $152K | +3.0% | +6.4% | N/A |
| NARI | SELL · 10b5-1 | 2024-10-29 | 2024-10-31 | $50.00 | $150K | +5.7% | +7.4% | +64.2% |
| NARI | SELL · 10b5-1 | 2024-08-20 | 2024-08-22 | $50.00 | $150K | -5.0% | -4.8% | +8.0% |
| NARI | SELL · 10b5-1 | 2024-07-22 | 2024-07-24 | $55.23 | $166K | -17.4% | -22.5% | -20.5% |
| NARI | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $50.08 | $150K | +16.5% | -5.0% | -18.4% |
| NARI | SELL · 10b5-1 | 2024-05-28 | 2024-05-30 | $50.00 | $150K | -5.4% | -0.2% | -13.0% |
| NARI | SELL | 2023-11-16 | 2023-11-17 | $59.72 | $3.5M | +4.4% | +14.6% | +3.2% |
| NARI | SELL | 2023-08-16 | 2023-08-18 | $66.10 | $4.8M | +8.9% | +3.6% | -7.5% |
| NARI | SELL | 2023-05-16 | 2023-05-18 | $70.01 | $5.1M | -8.8% | -11.6% | -2.0% |
| NARI | SELL | 2023-03-20 | 2023-03-21 | $64.24 | $1.0M | -5.1% | +2.5% | -10.1% |
| NARI | SELL | 2023-02-21 | 2023-02-22 | $55.19 | $497K | +1.1% | +11.9% | +12.3% |
| NARI | SELL | 2023-01-20 | 2023-01-24 | $61.90 | $557K | -3.8% | -10.0% | +14.5% |
| NARI | SELL | 2022-12-20 | 2022-12-22 | $68.43 | $890K | -7.1% | -8.5% | -9.5% |
| NARI | SELL | 2022-11-21 | 2022-11-22 | $77.66 | $1.4M | -6.8% | -10.2% | -29.0% |
| NARI | SELL | 2022-10-20 | 2022-10-24 | $72.30 | $1.3M | -5.5% | +2.8% | -15.2% |
| NARI | SELL | 2022-09-06 | 2022-09-08 | $70.00 | $350K | -7.2% | -4.5% | -7.8% |
| NARI | SELL | 2022-08-01 | 2022-08-03 | $78.89 | $679K | +4.0% | -16.6% | -5.9% |
| NARI | SELL | 2022-07-05 | 2022-07-06 | $70.31 | $352K | +1.0% | +16.7% | +4.5% |
| NARI | SELL | 2022-06-07 | 2022-06-09 | $70.08 | $350K | +0.4% | +12.5% | +15.1% |
| NARI | SELL | 2022-05-02 | 2022-05-04 | $79.70 | $773K | -26.7% | -18.1% | -1.2% |
| NARI | SELL | 2022-04-01 | 2022-04-05 | $91.16 | $1.8M | -2.8% | -20.3% | -18.2% |
| NARI | SELL | 2022-02-28 | 2022-03-02 | $90.39 | $3.1M | -22.0% | -6.4% | -32.3% |
| NARI | SELL | 2022-02-01 | 2022-02-03 | $73.82 | $568K | +12.2% | +31.5% | +17.0% |
| NARI | SELL | 2022-01-18 | 2022-01-20 | $76.45 | $627K | +2.6% | +6.2% | +28.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.